---
title: "BetterLife Pharma Launches $500,000 Private Placement to Advance LSD-Derived Neurology Drug"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282103310.md"
description: "BetterLife Pharma Launches $500,000 Private Placement to Advance LSD-Derived Neurology Drug"
datetime: "2026-04-08T22:19:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282103310.md)
  - [en](https://longbridge.com/en/news/282103310.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282103310.md)
---

# BetterLife Pharma Launches $500,000 Private Placement to Advance LSD-Derived Neurology Drug

BetterLife Pharma Launches $500,000 Private Placement to Advance LSD-Derived Neurology Drug

### Related Stocks

- [SAVU.US](https://longbridge.com/en/quote/SAVU.US.md)

## Related News & Research

- [Lupin bets big on India's GLP-1 market & respiratory drugs](https://longbridge.com/en/news/287021542.md)
- [00:45 ETAraceli Biosciences Launches Endeavor® Live Cell for Ultra-High-Throughput Kinetic Imaging in AI-Driven Drug Discovery](https://longbridge.com/en/news/287006505.md)
- [‘Solve all diseases,’ you say?](https://longbridge.com/en/news/287121830.md)
- [Angelini Buyout And Firdapse Settlement Reframe Catalyst Pharmaceuticals Story](https://longbridge.com/en/news/286669201.md)
- [Eli Lilly (LLY) Is the Face of the Obesity Boom. Has the Market Already Priced It In?](https://longbridge.com/en/news/286727957.md)